Clinical Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
FUSN | A | Fusion Pharmaceuticals Inc. | 0.14 | |
CRVO | A | CervoMed Inc. | -0.36 | |
VNDA | A | Vanda Pharmaceuticals Inc. | 4.23 | |
MACK | A | Merrimack Pharmaceuticals, Inc. | 0.34 | |
KRYS | A | Krystal Biotech, Inc. | -4.09 | |
NKTR | A | Nektar Therapeutics | -4.92 | |
DCTH | B | Delcath Systems, Inc. | 1.60 | |
XTLB | B | XTL Biopharmaceuticals Ltd. | 0.00 | |
LIXT | B | Lixte Biotechnology Holdings, Inc. | 3.43 | |
LDOS | B | Leidos Holdings, Inc. | 0.90 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
SHLD | A | Global X Defense Tech ETF | 4.52 | |
MISL | B | First Trust Indxx Aerospace & Defense ETF | 4.38 | |
HELX | D | Franklin Genomic Advancements ETF | 4.36 | |
JFWD | C | Jacob Funds Inc. Jacob Forward ETF | 3.45 | |
CIBR | C | First Trust NASDAQ CEA Cybersecurity ETF | 3.14 |
Compare ETFs
- Clinical Development
Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.
Popular Now
Recent Comments
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
- TraderMike on Market Recap for Friday, March 8, 2024
- Don_Marat on Market Recap for Friday, March 8, 2024
From the Blog
Featured Articles